The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Enyedy Mark J since 2016.
This trader's CIK number is 1586965.
At the time of last reporting, Enyedy Mark J was the CHIEF EXECUTIVE OFFICER of Immunogen, Inc.. (stock ticker symbol IMGN).
Also see all insider trading activities at Immunogen, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | IMGN | 0 | $0 | 20,107 | $588,732 | 51,234 | $0 |
2023 | IMGN | 0 | $0 | 3,007,554 | $51,487,047 | 3,119,375 | $15,212,686 |
2020 | IMGN | 0 | $0 | 55,222 | $275,557 | 0 | $0 |
2018 | IMGN | 0 | $0 | 51,070 | $285,992 | 0 | $0 |
2018 | IMGN | 0 | $0 | 67,717 | $736,083 | 0 | $0 |
2016 | IMGN | 25,000 | $45,750 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | LOGC | 0 | $0 | 0 | $0 | 2,921 | $0 |
2. Logicbio Therapeutics, Inc. (LOGC)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-02-02 | IMGN | Option Ex | 51,234 | .00 | 0 |
2024-02-05 | IMGN | Sale | 20,107 | 29.28 | 588,732 |
2023-08-02 | IMGN | Option Ex | 995,157 | 4.55 | 4,527,964 |
2023-08-03 | IMGN | Option Ex | 1,020,000 | 4.90 | 4,998,000 |
2023-08-02 | IMGN | Sale | 995,157 | 17.80 | 17,713,794 |
2023-08-04 | IMGN | Option Ex | 1,104,218 | 5.15 | 5,686,722 |
2023-08-03 | IMGN | Sale | 1,020,000 | 16.61 | 16,942,200 |
2023-08-04 | IMGN | Sale | 992,397 | 16.96 | 16,831,053 |
2020-02-24 | IMGN | Sale | 55,222 | 4.99 | 275,557 |
2018-02-22 | IMGN | Sale | 51,070 | 5.60 | 285,992 |
2018-02-21 | IMGN | Sale | 67,717 | 10.87 | 736,083 |
2016-11-08 | IMGN | Buy | 25,000 | 1.83 | 45,750 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-01-01 | LOGC | Option Ex | 2,921 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Enyedy Mark J (CHIEF EXECUTIVE OFFICER of Immunogen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.